StockData
Regentis Biomaterials Ltd. logo

Regentis Biomaterials Ltd. (RGNT) stock

RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 24, 2026Score 1/30
$1.14−0.08 (-6.56%)

Close on Nov 18, 2026Market cap $5.90MP/E –Yield –

Regentis Biomaterials pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Regentis Biomaterials's pe ratio was 2.3× on Feb 27, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Feb 27, 20262.3×−1.6
2025Dec 31, 20253.9×–

More Regentis Biomaterials figures

See a number that looks wrong?